The global learning disabilities treatment market is projected to grow significantly in the coming years, driven by factors such as increasing prevalence of learning disabilities, heightened awareness, and advancements in treatment options. This report provides insights into market trends, key players, and regional growth prospects.
A recent study in the UK has investigated the prevalence of long COVID in people with diabetes. Long COVID refers to the prolonged persistence of symptoms after SARS-CoV-2 infection. The study found that individuals with type 2 diabetes (T2D) were more likely to develop long COVID compared to non-diabetic controls, while those with type 1 diabetes (T1D) were less likely. Researchers suggest that further research is needed to understand the factors that influence the risk of developing long COVID, particularly in people with diabetes.
